Patients with the rs1799971 GG genotype may have increased opioid dose requirements as compared to patients with the AA or AG genotypes. However, conflicting evidence has been reported. This drug-variant pair has been assigned a 鈥渘o recommendation鈥?by CPIC, as it was determined to be not clinically actionable. Other genetic or clinical factors may also affect opioid dose requirements.